红日药业出局深证成指样本股 姚小青正拟套现约1.8亿

Group 1 - The Shenzhen Stock Exchange and Shenzhen Securities Information Co., Ltd. announced adjustments to the sample stocks of various indices, including the Shenzhen Component Index and ChiNext Index, effective December 15, 2025 [1] - Hongri Pharmaceutical (300026) has been removed from the Shenzhen Component Index sample stock list [2] - A list of stocks being added and removed from the indices was provided, with notable additions including Deep Shenzhen A (000029) and Demingli (608100), while notable removals include Guoyao Yizhi (000028) and Hongri Pharmaceutical (300026) [3] Group 2 - Shareholder Yao Xiaoqing plans to reduce his holdings by up to 46,936,332 shares, representing 1.5624% of the total share capital, within three months following the announcement [2] - Senior management members also plan to reduce their holdings, with a total potential reduction of 47,337,332 shares, equating to 1.5757% of the total share capital [2] - The total estimated cash from the planned reductions is approximately 179,408,488.28 yuan, with Yao Xiaoqing's portion being 177,888,698.28 yuan based on the last closing price of 3.79 yuan [2] Group 3 - Yao Xiaoqing, the second-largest shareholder of Hongri Pharmaceutical, held 10.24% of the shares as of September 30, 2024, and has been the chairman from April 22, 2022, to April 1, 2024 [4] - Yao Xiaoqing has a history of share reductions, having cumulatively sold 117 million shares since July 2, 2013, amounting to approximately 851 million yuan [5]